Venture Visionary Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.01M Buy
6,746
+618
+10% +$86.7K 0.03% 353
2026
Q2
$774K Sell
6,128
-144
-2% -$19K 0.02% 390
2026
Q1
$874K Sell
6,272
-150
-2% -$21K 0.03% 337
2025
Q4
$788K Buy
6,422
+76
+1% +$9.24K 0.03% 350
2025
Q3
$704K Buy
6,346
+189
+3% +$21.5K 0.02% 350
2025
Q2
$683K Sell
6,157
-224
-4% -$23.8K 0.03% 343
2025
Q1
$715K Sell
6,381
-505
-7% -$52.1K 0.03% 324
2024
Q4
$636K Sell
6,886
-819
-11% -$73.7K 0.03% 322
2024
Q3
$646K Sell
7,705
-683
-8% -$52.1K 0.03% 329
2024
Q2
$576K Buy
8,388
+967
+13% +$64.5K 0.03% 351
2024
Q1
$544K Buy
7,421
+69
+0.9% +$5.31K 0.03% 361
2023
Q4
$596K Buy
7,352
+333
+5% +$25.9K 0.03% 332
2023
Q3
$526K Sell
7,019
-476
-6% -$36.6K 0.03% 321
2023
Q2
$578K Sell
7,495
-295
-4% -$23.5K 0.03% 317
2023
Q1
$646K Sell
7,790
-380
-5% -$31.5K 0.04% 296
2022
Q4
$701K Sell
8,170
-411
-5% -$32.5K 0.05% 267
2022
Q3
$529K Sell
8,581
-26,032
-75% -$1.64M 0.04% 293
2022
Q2
$2.14M Sell
34,613
-8,787
-20% -$544K 0.16% 118
2022
Q1
$2.58M Sell
43,400
-5,974
-12% -$382K 0.17% 115
2021
Q4
$3.62M Buy
49,374
+2,903
+6% +$200K 0.24% 95
2021
Q3
$3.27M Buy
46,471
+6,827
+17% +$480K 0.23% 95
2021
Q2
$2.79M Buy
39,644
+21,362
+117% +$1.43M 0.22% 100
2021
Q1
$1.18M Buy
18,282
+11,311
+162% +$729K 0.1% 179
2020
Q4
$406K Buy
+6,971
New +$421K 0.04% 268

Other funds holding GILD

Venture Visionary Partners's GILD Position: Q3 2026 in Review

Venture Visionary Partners increased its Gilead Sciences (GILD) stake by 10% in Q3 2026, buying an estimated $86.7K and bringing the position to 6,746 shares worth $1.01M. The position accounts for 0.03% of the portfolio, ranked #353.

Venture Visionary Partners first reported a position in GILD in Q4 2020 and has held it in 24 quarters since. The position peaked at $3.62M in Q4 2021. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Venture Visionary Partners held 6,746 shares of Gilead Sciences worth $1.01M as of Q3 2026.
  • Venture Visionary Partners bought 618 Gilead Sciences shares in Q3 2026, an estimated $86.7K.
  • Gilead Sciences made up 0.03% of Venture Visionary Partners's portfolio in Q3 2026, its #353 holding.
  • Venture Visionary Partners first reported a position in Gilead Sciences in Q4 2020 and has held it in 24 quarters since.
  • Venture Visionary Partners's Gilead Sciences position peaked at $3.62M in Q4 2021.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Venture Visionary Partners's 13F filing for Q3 2026, filed 7 Oct 2026.